(24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-9-[2-(1-methyl-2,2-dipropylhydrazino)-2-oxoethoxy]-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate (38123-35-2)

Identification
Name:	(24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-9-[2-(1-methyl-2,2-dipropylhydrazino)-2-oxoethoxy]-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
Synonyms:	Rifamycin B dipropylmethylhydrazide;NSC 145608;BRN 5418698;Acetic acid, ((1,2-dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-9-yl)oxy)-, 21-acetate, 2,2-dipropyl-1-methylhydrazide;38123-35-2;LS-11767;Rifamycin, 4-O-(2-(1-methyl-2,2-dipropylhydrazino)-2-oxoethyl)-;Rifamycin, 4-O-(2-(1-methyl-2,2-dipropylhydrazino)-2-oxoethyl)- (9CI)
CAS:	38123-35-2
Molecular Formula:	C₄₆H₆₅N₃O₁₃
Molecular Weight:	868.0206
InChI:	InChI=1/C46H65N3O13/c1-13-19-49(20-14-2)48(11)34(51)23-59-33-22-31-41(55)36-35(33)37-43(29(8)40(36)54)62-46(10,44(37)56)60-21-18-32(58-12)26(5)42(61-30(9)50)28(7)39(53)27(6)38(52)24(3)16-15-17-25(4)45(57)47-31/h15-18,21-22,24,26-28,32,38-39,42,52-55H,13-14,19-20,23H2,1-12H3,(H,47,57)/b16-15+,21-18+,25-17u
Molecular Structure:
Properties
Density:	1.28g/cm³
Refractive index:	1.605
Safety Data